UBS Group’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.16M Buy
703,167
+63,476
+10% +$331K ﹤0.01% 4540
2025
Q4
$3.93M Buy
639,691
+147,045
+30% +$1.07M ﹤0.01% 4266
2025
Q3
$3.56M Sell
492,646
-304,348
-38% -$1.81M ﹤0.01% 4390
2025
Q2
$4.23M Buy
796,994
+248,496
+45% +$1.47M ﹤0.01% 4045
2025
Q1
$4.87M Buy
548,498
+70,926
+15% +$852K ﹤0.01% 3810
2024
Q4
$6.55M Buy
477,572
+273,613
+134% +$5.05M ﹤0.01% 3526
2024
Q3
$5.59M Buy
203,959
+82,072
+67% +$2.22M ﹤0.01% 2966
2024
Q2
$2.98M Sell
121,887
-88,382
-42% -$1.94M ﹤0.01% 3358
2024
Q1
$4.48M Buy
210,269
+41,453
+25% +$891K ﹤0.01% 3089
2023
Q4
$3.23M Buy
168,816
+98,056
+139% +$1.7M ﹤0.01% 3276
2023
Q3
$1.13M Sell
70,760
-39,781
-36% -$757K ﹤0.01% 3959
2023
Q2
$2.56M Buy
110,541
+33,952
+44% +$741K ﹤0.01% 3291
2023
Q1
$1.78M Sell
76,589
-107,464
-58% -$2.18M ﹤0.01% 3555
2022
Q4
$2.67M Buy
184,053
+149,281
+429% +$2.78M ﹤0.01% 3098
2022
Q3
$664K Sell
34,772
-3,190
-8% -$73.2K ﹤0.01% 4097
2022
Q2
$690K Sell
37,962
-102,877
-73% -$2.14M ﹤0.01% 4022
2022
Q1
$3.55M Sell
140,839
-40,951
-23% -$1.05M ﹤0.01% 2886
2021
Q4
$5.02M Buy
181,790
+82,041
+82% +$2.38M ﹤0.01% 2814
2021
Q3
$3.22M Buy
99,749
+88,214
+765% +$2.93M ﹤0.01% 3144
2021
Q2
$353K Sell
11,535
-95,989
-89% -$2.77M ﹤0.01% 4970
2021
Q1
$3.27M Buy
107,524
+20,322
+23% +$577K ﹤0.01% 3037
2020
Q4
$1.73M Buy
87,202
+73,997
+560% +$1.19M ﹤0.01% 3539
2020
Q3
$172K Buy
13,205
+4,675
+55% +$59.2K ﹤0.01% 4879
2020
Q2
$97K Sell
8,530
-26,561
-76% -$377K ﹤0.01% 5329
2020
Q1
$502K Sell
35,091
-32,815
-48% -$693K ﹤0.01% 3958
2019
Q4
$1.85M Sell
67,906
-110,436
-62% -$3.04M ﹤0.01% 3632
2019
Q3
$5.11M Buy
178,342
+158,832
+814% +$4.63M ﹤0.01% 2364
2019
Q2
$542K Buy
19,510
+998
+5% +$28.2K ﹤0.01% 4236
2019
Q1
$615K Sell
18,512
-171,649
-90% -$5.23M ﹤0.01% 3925
2018
Q4
$5.53M Buy
190,161
+171,079
+897% +$6.15M ﹤0.01% 2059
2018
Q3
$878K Sell
19,082
-2,477
-11% -$110K ﹤0.01% 3956
2018
Q2
$805K Sell
21,559
-124,777
-85% -$4.21M ﹤0.01% 3954
2018
Q1
$4.32M Buy
146,336
+106,258
+265% +$3.6M ﹤0.01% 2449
2017
Q4
$1.38M Buy
40,078
+2,473
+7% +$83.4K ﹤0.01% 3503
2017
Q3
$1.36M Sell
37,605
-19,532
-34% -$557K ﹤0.01% 3448
2017
Q2
$1.48M Sell
57,137
-66,843
-54% -$1.42M ﹤0.01% 3281
2017
Q1
$2.38M Sell
123,980
-32,950
-21% -$584K ﹤0.01% 2783
2016
Q4
$2.62M Buy
156,930
+49,961
+47% +$904K ﹤0.01% 2667
2016
Q3
$2.2M Buy
106,969
+10,715
+11% +$272K ﹤0.01% 2750
2016
Q2
$2.95M Buy
96,254
+75,208
+357% +$2.61M ﹤0.01% 2444
2016
Q1
$788K Sell
21,046
-5,667
-21% -$214K ﹤0.01% 3441
2015
Q4
$1.15M Sell
26,713
-53,726
-67% -$2.27M ﹤0.01% 3293
2015
Q3
$3.02M Buy
80,439
+5,742
+8% +$204K ﹤0.01% 2370
2015
Q2
$2.54M Buy
74,697
+40,274
+117% +$1.37M ﹤0.01% 2743
2015
Q1
$1.22M Sell
34,423
-34,291
-50% -$1.23M ﹤0.01% 3393
2014
Q4
$2.34M Buy
+68,714
New +$2.44M ﹤0.01% 2755

Other funds holding MYGN